icon

Kinase Test May Yield Big Gains for Drug-Resistant Cancers

December 05, 2020

A UNC research team, led by Gary Johnson, PhD, has developed a test that can measure both the presence and activity of 60-70 percent of all kinases simultaneously, allowing investigators to see how cancers evade treatment with kinase inhibitors so that they can combine drugs to block resistance. Read more at http://news.unchealthcare.org/news/2012/april/kinase-test-may-yield-big-gains-for-drug-resistant-cancers



Also in News

Lindi Skin honors Dr. Kenneth M. Algazy
Lindi Skin honors Dr. Kenneth M. Algazy

January 05, 2023

Read More

Guest Post: The Kindness Campaign discusses Skincare during Immunotherapy

January 04, 2022

Read More

Why does Lindi Skin contain fragrances?

December 01, 2021

Fragrance is one of the key decisions to be made when creating any skincare products, and our team of doctors, formulators and skincare experts created our formulas with very explicit instructions to design the products without any unnecessary fragrances, dyes, or ingredients.   

However, the key word here is “unnecessary”. 

Read More

Liquid error (layout/theme line 316): Could not find asset snippets/afterpay.liquid